Search results for "ARM"

showing 10 items of 19046 documents

Towards sustainable farming practices and food security: study about vulnerability of Finnish farms

2017

The aim of this paper is to discuss food security in the context of sustainable farming practices in Finland. There are two research questions: 1) How are the Finnish farms vulnerable from the viewpoint of food security? 2) How could they increase their resilience for guaranteeing food security in the future? The paper is based on a qualitative study for which 15 Finnish food system specialists were interviewed in 2015. According to the results, three types of vulnerabilities are discovered: 1) market vulnerabilities, 2) continuity of farms, and 3) environment changes. For reducing vulnerabilities, the re-evaluation of policy instruments is needed. At the same time, new knowledge and skills…

ruokaturvaComputingMilieux_THECOMPUTINGPROFESSIONSuomifarming practicesFinlandmaanviljelymaaseutusosiologia
researchProduct

Polifenoli un fenolskābes kā dziļās glikēšanas gala produktu veidošanās inhibitori in vitro

2022

Tiek uzskatīts, ka dziļās glikēšanas gala produktu (AGE) inhibitoriem ir terapeitisks potenciāls pacientiem, kuriem ir ar vecumu saistītas slimības, piemēram, diabēts, neirodeģenerācija, ateroskleroze. Šī bakalaura darba mērķis bija izpētīt fenolskābju galluskābes, hlorogēnskābes un polifenolu rutīna un kvercetīna ietekmi uz AGE veidošanos in vitro. AGE inhibīcijas īpašības tika pētītas in vitro, izmantojot divas modeļu sistēmas: liellopu seruma albumīns ar metilglioksālu un liellopu seruma albumīns ar glikozi. In vitro pētījumi liecināja par polifenolu un fenolskābju būtisku inhibējošu iedarbību uz AGE veidošanos. Visspēcīgākais glikācijas inhibitors bija rutīns. Visvājākais glikācijas inh…

rutīnsAGEhlorogēnskābegallu skābeFarmācijainhibīcija
researchProduct

Katsaus ryhmän vuorovaikutuksen analysointimenetelmiin

2011

Ryhmän vuorovaikutuksen tutkimukseen on kehitetty useita analysointimenetelmiä, joiden tavoitteena on kuvata, ymmärtää ja selittää ryhmän jäsenten välistä vuorovaikutusta ja ryhmän vuorovaikutusprosesseja. Tunnetuimpia lienevät keskusteluanalyysi (ks. esim. Heritage 1997; Peräkylä 1995) ja Balesin (1951) vuorovaikutuksen prosessianalyysi (IPA). Tämän kirjallisuuskatsauksen tavoitteena on jäsentää ja arvioida, millaisia ryhmän vuorovaikutuksen havainnointiin perustuvia analyysimenetelmiä on käytetty tehtäväkeskeisten ryhmien ja tiimien tutkimuksessa vuosina 1999–2009. Artikkeli pohjautuu systemaattiseen tiedonhakuun, joka keskittyi tärkeimpiin puheviestinnän ja lähitieteiden artikkelitietoka…

ryhmävuorovaikutustiimiPharmacology (medical)analyysimenetelmätArtikkelitpuheviestintäanalyysimenetelmä
researchProduct

Bodźce pozacenowe w kontraktach rolnych. Powiązania umowne między grupami producentów rolnych a ich pierwszymi odbiorcami w Polsce

2018

Celem artykułu jest identyfikacja stosowanych bodźców pozacenowych w umowach rolnych, które mogłyby potencjalnie skłaniać agenta do działania zgodnego z interesem kontraktora. Zastosowanie tego typu zachęt może potencjalnie minimalizować problem pokusy nadużycia ze strony agenta jeszcze w trakcie jej obowiązywania, tj. w trakcie produkcji rolnej. Dla realizacji założonego celu wykorzystano badanie własne z użyciem ankiety. Badanie empiryczne przeprowadzono wśród grup producentów rolnych działających na rynku drobiu, a przedmiotem badań były kontrakty rolne podpisane w 2014 roku. Na podstawie przeprowadzonych badań zidentyfikowano bodźce pozacenowe, które mają pomóc monitorować i łagodzić pr…

rynek drobiubodźce pozacenoweagricultural producers’ groupskontrakt rolnypoultry marketfarming contractnon-price incentivesgrupy producentów rolnychRoczniki Naukowe Stowarzyszenia Ekonomistów Rolnictwa i Agrobiznesu
researchProduct

Vita e martirio di san Bartolomeo apostolo

2012

Si ripropone al lettore del secolo XXI in traduzione italiana, corredandolo di ampie note di aggiornamento e di discussione, il volumetto miscellaneo (1877) con cui il Moesinger rendeva accessibile agli uomini di cultura la narrazione della predicazione e del martirio di San Bartolomeo apostolo contenuta nel Martirologio armeno. Si trattò di una lettura innovativa condotta con il rigore del filologo, che diede impulso agli studi di agiografia comparativa che si conducevano soprattutto sugli apocrifi Atti degli Apostoli. La collazione dei testi qui rappresentati, provenienti da ambiti storiografici diversi, ci fornisce un’informazione attendibile sui primi tentativi di evangelizzazione di qu…

s. BartolomeoGeorg MoesingerSettore L-OR/13 - Armenistica Caucasologia Mongolistica E TurcologiaSettore L-FIL-LET/06 - Letteratura Cristiana Anticatesto criticoArmeniaSettore L-FIL-LET/05 - Filologia ClassicaSettore L-OR/07 - Semitistica - Lingue E Letterature Dell'Etiopia
researchProduct

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in h…

2021

A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults ≥65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been evaluated in adults aged 60–64 y. This study compared immunogenicity and safety of IIV4-HD with a standard-dose quadrivalent influenza vaccine (IIV4-SD) in adults aged ≥60 y. This Phase III, randomized, modified double-blind, active-controlled study enrolled 1,528 participants aged ≥60 y, randomized 1:1 to a single injection of IIV4-HD or IIV4-SD. Hemagglutination inhibition (HAI) geometric mean titers (GMTs) were measured at baseline and D 28 and seroconversion assessed. Safety was described for 180 d after vaccinat…

safetyAdultIMPACTInfluenza vaccineImmunologyimmunogenicityAntibodies ViralQuadrivalent Influenza Vaccineolder adultImmunogenicity VaccineDouble-Blind MethodInfluenza HumanMedicine and Health SciencesImmunology and AllergyMedicineHumansVaccines Combinedolder adultsPharmacologybusiness.industryImmunogenicityADULTSHemagglutination Inhibition TestsEFFICACYVirologyinfluenza vaccinationHigh-dose influenza vaccineVaccines InactivatedInfluenza VaccinesPhase III trialbusinessHuman vaccinesimmunotherapeutics
researchProduct

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in De…

2020

Background: Registry studies broadly describing the safety of systemic drugs in psoriasis are needed. Objective: To describe the safety findings of the systemic drugs acitretin, adalimumab, apremilast, cyclosporine, etanercept, infliximab, methotrexate, secukinumab, and ustekinumab used for the treatment of moderate to severe psoriasis in patients included in the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry. Methods: The incidence rate ratio (IRR) and adjusted IRR (including propensity scores) of identified adverse events for each drug, using methotrexate as reference, were determined by means of a prospective cohort. Results: O…

safetyAdultMalemedicine.medical_specialtyTime Factorsbiologic agentsprospective cohortlong-term follow-upDermatologyimmunosuppressive agentsanti-inflammatory agentsCohort Studies030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinePsoriasisUstekinumabmedicineAdalimumabHumansPsoriasisRegistriesAdverse effectProspective cohort studyAgedbusiness.industryregistriespsoriasis/drug therapyanti-TNFMiddle Agedmedicine.diseaseInfliximabBiological TherapySpain030220 oncology & carcinogenesispharmacovigilanceadverse effectsSecukinumabFemaleApremilastbusinessmedicine.drugJournal of the American Academy of Dermatology
researchProduct

Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor

2020

Introduction: The discovery and the clinical availability of novel cyclin-dependent kinases 4 and 6 inhibitors have profoundly changed the therapeutic scenario of metastatic hormone receptor-positive breast carcinoma. Among these inhibitors, abemaciclib can induce potent and sustained cell cycle arrest and immune system stimulation. Areas covered: This review summarizes the safety profile and clinical efficacy data on abemaciclib alone or in combination with aromatase inhibitors or fulvestrant in metastatic hormone receptor-positive breast carcinoma. The management of patients treated with abemaciclib is the object of this paper. Expert opinion: As shown in phase 2 and 3 clinical trials on …

safetyAminopyridinesBreast Neoplasms030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundabemaciclib breast cancer metastases hormonal receptors safetybreast cancer0302 clinical medicineBreast cancerCyclin-dependent kinaseAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPharmacology (medical)metastasesskin and connective tissue diseasesFulvestrantProtein Kinase InhibitorsAbemaciclibbiologyAromatase Inhibitorsbusiness.industryKinasehormonal receptorsCyclin-Dependent Kinase 4Cell Cycle CheckpointsCyclin-Dependent Kinase 6General Medicinemedicine.diseaseAbemaciclibchemistry030220 oncology & carcinogenesisQuality of LifeCancer researchbiology.proteinBenzimidazolesFemalesense organsbusinessHormone
researchProduct

Polyphenols and Pharmacological Screening of a Monarda fistulosa L. dry Extract Based on a Hydrodistilled Residue By-Product

2021

This study aimed to determine the composition and content of polyphenols in the dry extract obtained from the hydrodistilled residue by-product of the wild bergamot (Monarda fistulosa L., Lamiaceae Martinov family) herb (MFDE) and to evaluate its safety and pharmacological properties. The total phenolic content (TPC) in the MFDE was 120.64 mg GAE/g. The high-performance liquid chromatography (HPLC) analysis showed the presence of a plethora of phenolic compounds, including hydroxycinnamic acids and flavone derivatives in the MFDE, with rosmarinic acid and luteolin-7-O-glucoside being the main components. With an IC50 value of 0.285 mg/mL, it was found to be a strong DPPH radical scavenger. …

safetyDPPHRM1-950phenolic compoundsMonarda fistulosa01 natural sciencesHigh-performance liquid chromatographywild bergamot03 medical and health scienceschemistry.chemical_compound0302 clinical medicineantiradical activityPharmacology (medical)anti-inflammatory activityanalgesic activityOriginal ResearchPharmacologyResidue (complex analysis)biologyTraditional medicine010405 organic chemistryRosmarinic acidbiology.organism_classificationAcute toxicity0104 chemical scienceschemistryherbPolyphenol030220 oncology & carcinogenesispostdistillation wasteLamiaceaeTherapeutics. PharmacologyFrontiers in Pharmacology
researchProduct

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

2020

Funding: Transgène; International audience; Treatment of chronic hepatitis B (CHB) typically requires life-long administration of drugs. Cohort and pre-clinical studies have established the link between a functional T-cell-mounted immunity and resolution of infection. TG1050 is an adenovirus 5-based vaccine that expresses HBV polymerase and domains of core and surface antigen and has shown immunogenicity and antiviral effects in mice. We performed a phase 1 clinical trial to assess safety and explore immunogenicity and early efficacy of TG1050 in CHB patients. This randomized, double blind, placebo-controlled study included two sequential phases: one single dose cohort (SD, n = 12) and one …

safetyHBsAg030231 tropical medicineImmunologyPlacebo-controlled studyPhases of clinical researchSciences du Vivant [q-bio]/Médecine humaine et pathologieimmunogenicityPlaceboAntiviral AgentsAdenoviridae03 medical and health sciencesMice0302 clinical medicineHepatitis B ChronicImmunogenicity VaccinevaccineImmunology and AllergyMedicineAnimalsHumans030212 general & internal medicineAdverse effectPharmacologyVaccinesHepatitis B Surface Antigens[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryELISPOTImmunogenicitychronicityimmuno-therapyHepatitis Bmedicine.diseaseHepatitis B3. Good healthImmunologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyResearch Paper
researchProduct